Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 231

1.

Overcoming in vivo barriers to targeted nanodelivery.

Chrastina A, Massey KA, Schnitzer JE.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Jul-Aug;3(4):421-37. doi: 10.1002/wnan.143. Epub 2011 Apr 27. Review.

PMID:
21538941
2.

Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles.

Shokeen M, Fettig NM, Rossin R.

Q J Nucl Med Mol Imaging. 2008 Sep;52(3):267-77. Epub 2008 May 13. Review.

3.

Disposition of nanoparticle-based delivery system via inner ear administration.

Chen G, Zhang X, Yang F, Mu L.

Curr Drug Metab. 2010 Dec;11(10):886-97. Review.

PMID:
21208174
4.

Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.

Koning GA, Krijger GC.

Anticancer Agents Med Chem. 2007 Jul;7(4):425-40. Review.

PMID:
17630918
5.

Drug nanocarriers and functional nanoparticles: applications in cancer therapy.

Thierry B.

Curr Drug Deliv. 2009 Aug;6(4):391-403. Epub 2009 Aug 1. Review.

PMID:
19534706
6.

Targeted nanoparticle-based drug delivery and diagnosis.

Emerich DF, Thanos CG.

J Drug Target. 2007 Apr;15(3):163-83. Review.

PMID:
17454354
7.

Nanotechnology-based cancer therapeutics--promise and challenge--lessons learned through the NCI Alliance for Nanotechnology in Cancer.

Farrell D, Ptak K, Panaro NJ, Grodzinski P.

Pharm Res. 2011 Feb;28(2):273-8. doi: 10.1007/s11095-010-0214-7. Epub 2010 Aug 6.

PMID:
20814720
8.

Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.

Feng SS, Mu L, Win KY, Huang G.

Curr Med Chem. 2004 Feb;11(4):413-24.

PMID:
14965222
9.

Micro- and nanoparticles--medical applications.

Jătariu A, Peptu C, Popa M, Indrei A.

Rev Med Chir Soc Med Nat Iasi. 2009 Oct-Dec;113(4):1160-9. Review.

PMID:
20191893
10.

Targeted drugs and nanomedicine: present and future.

Debbage P.

Curr Pharm Des. 2009;15(2):153-72. Review.

PMID:
19149610
11.

Nanoparticulate delivery systems for antiviral drugs.

Lembo D, Cavalli R.

Antivir Chem Chemother. 2010;21(2):53-70. doi: 10.3851/IMP1684. Review.

PMID:
21107015
12.

Development of nanoparticles for antimicrobial drug delivery.

Zhang L, Pornpattananangku D, Hu CM, Huang CM.

Curr Med Chem. 2010;17(6):585-94. Review.

PMID:
20015030
13.

Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.

Rosenholm JM, Sahlgren C, Lindén M.

Nanoscale. 2010 Oct;2(10):1870-83. doi: 10.1039/c0nr00156b. Epub 2010 Aug 23. Review.

PMID:
20730166
14.

Nanoparticle formulations in pulmonary drug delivery.

Bailey MM, Berkland CJ.

Med Res Rev. 2009 Jan;29(1):196-212. doi: 10.1002/med.20140. Review.

PMID:
18958847
15.

Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage.

Rosenholm JM, Mamaeva V, Sahlgren C, Lindén M.

Nanomedicine (Lond). 2012 Jan;7(1):111-20. doi: 10.2217/nnm.11.166. Review.

PMID:
22191780
16.

To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.

Danhier F, Feron O, Préat V.

J Control Release. 2010 Dec 1;148(2):135-46. doi: 10.1016/j.jconrel.2010.08.027. Epub 2010 Aug 24. Review.

PMID:
20797419
17.

Using nanotechnology to design potential therapies for CNS regeneration.

Ellis-Behnke RG, Teather LA, Schneider GE, So KF.

Curr Pharm Des. 2007;13(24):2519-28. Review.

PMID:
17692020
18.

Clinical developments in nanotechnology for cancer therapy.

Heidel JD, Davis ME.

Pharm Res. 2011 Feb;28(2):187-99. doi: 10.1007/s11095-010-0178-7. Epub 2010 Jun 12. Review.

PMID:
20549313
19.

Targeting of nanoparticles in cancer: drug delivery and diagnostics.

Talekar M, Kendall J, Denny W, Garg S.

Anticancer Drugs. 2011 Nov;22(10):949-62. doi: 10.1097/CAD.0b013e32834a4554. Review.

PMID:
21970851
20.

Challenges to macromolecular drug delivery.

Juliano R.

Biochem Soc Trans. 2007 Feb;35(Pt 1):41-3. Review.

PMID:
17233596

Supplemental Content

Support Center